F.D.A. Approves a Drug for Late-Stage Pancreatic Cancer
The Food and Drug Administration has approved Abraxane, which in a clinical trial prolonged the lives of patients by a little less than two months on average. [Source]
Publication Date:Origin: nytimes.com
Category: Pancreatic Cancer
Topics: , average, months, little, patients, lives, prolonged, trial, clinical, which, Abraxane, approved, Administration, Cancer, Pancreatic, Late-Stage, Approves